Full Article:
Yahoo Finance
BiVACOR, a clinical-stage medical device company developing the world’s first titanium Total Artificial Heart (TAH), today announced that its device has received Breakthrough Device Designation from the U.
Keywords:
Huntington Beach, California, Business Wire, Food and Drug Administration
